Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells.

Cancer immunology, immunotherapy : CII - 1 Jun 2004

Hayashi Hiroki, Asano Ryutaro, Tsumoto Kouhei, Katayose Yu, Suzuki Masanori, Unno Michiaki, Kodama Hideaki, Takemura Shin-ichi, Yoshida Hiroshi, Makabe Koki, Imai Kohzoh, Matsuno Seiki, Kumagai Izumi, Kudo Toshio

Abstract excerpt

PURPOSE: In the field of cancer immunotherapy research, the targeting of effector cells with specific antibodies is a very promising approach. Recent advances in genetic engineering have made it possible to prepare immunoglobulin fragments consisting of variable domains using bacterial expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bispecific
Share to Bile Duct Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD3 Complex

Share to Granulocyte-Macrophage Colony-Stimulating Factor

Share to Hybridomas

Share to Interleukin-2

Share to Killer Cells, Lymphokine-Activated

Share to Mice, Inbred ICR

Source

Open in PubMed Open full text

Identifiers

PMID: 14648071
DOI: 10.1007/s00262-003-0465-9
PMCID: PMC11032808

Genes

EGFR
TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14648071-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells.PMID 14648071Read ↗

Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats.Semantic proximity Read ↗

Novel tetravalent and bispecific IgG‐like antibody molecules combining single‐chain diabodies with the immunoglobulin γ1 Fc or CH3 regionSemantic proximity Read ↗

A deimmunized bispecific ligand-directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic model.Semantic proximity Read ↗

Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applicationsSemantic proximity Read ↗

Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.Semantic proximity Read ↗

A new in vitro model of specific targeting therapy of cancer: retargeting of PWM-LAK cells with bispecific antibodies greatly enhances cytotoxicity to hepatocellular carcinoma.Semantic proximity Read ↗

Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.Semantic proximity Read ↗

Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation.Semantic proximity Read ↗

Liposome-encapsulated OK-432 specifically and sustainedly induces hepatic natural killer cells and intermediate T cell receptor cells.Semantic proximity Read ↗

Antitumor therapy with bacterial DNA and toxin: complete regression of established tumor induced by liposomal CpG oligodeoxynucleotides plus interleukin-13 cytotoxin.Semantic proximity Read ↗

Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.Semantic proximity Read ↗

Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.